Active: Response to fenofibrate Clear all

GWAS 2018-09-17

Family-based genome-wide association of inflammation biomarkers and fenofibrate treatment response in the GOLDN study.

Das S, Mondal PK et al.

BMC Proc

In this paper we analyzed whole-genome genetic information provided by GAW20 from the Genetics of Li...

Response to fenofibrate

778

Participants

N/A

Studies

Details PubMed

GWAS 2017-07-24

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

Rotroff DM, Pijut SS et al.

Clin Pharmacol Ther

Individuals with type 2 diabetes (T2D) and dyslipidemia are at an increased risk of cardiovascular d...

HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes

1264

Participants

N/A

Studies

Details PubMed

GWAS 2016-07-01

A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.

Irvin MR, Rotroff DM et al.

Pharmacogenet Genomics

Fibrates are commonly prescribed for hypertriglyceridemia, but they also lower LDL cholesterol and i...

Response to fenofibrate (HDL cholesterol levels)

Replicated

2082

Participants

N/A

Studies

Details PubMed

GWAS 2012-11-10

Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.

Aslibekyan S, An P et al.

Nutr Metab Cardiovasc Dis

Background and aims: Adiponectin is an adipose-secreted protein that has been linked to changes in i...

Response to fenofibrate (adiponectin levels)

793

Participants

N/A

Studies

Details PubMed

GWAS 2012-08-09

Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.

Frazier-Wood AC, Aslibekyan S et al.

Pharmacogenet Genomics

Objective: A shift towards overall larger very low-density lipoprotein (VLDL), and smaller low-densi...

Response to fenofibrate

817

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Family-based genome-wide association of inflammation biomarkers and fenofibrate treatment response in the GOLDN study.

Das S, Mondal PK et al.

BMC Proc

Response to fenofibrate

2018-09-17

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

Rotroff DM, Pijut SS et al.

Clin Pharmacol Ther

HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes

2017-07-24

A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.

Irvin MR, Rotroff DM et al.

Pharmacogenet Genomics

Response to fenofibrate (HDL cholesterol levels)

2016-07-01

Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.

Aslibekyan S, An P et al.

Nutr Metab Cardiovasc Dis

Response to fenofibrate (adiponectin levels)

2012-11-10

Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.

Frazier-Wood AC, Aslibekyan S et al.

Pharmacogenet Genomics

Response to fenofibrate

2012-08-09